Login

Seung-Mok Park

ORCID: 0009-0007-4718-8337
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5014481708
Research Areas
  • Pharmacovigilance and Adverse Drug Reactions
  • Drug-Induced Adverse Reactions
  • Inflammatory mediators and NSAID effects
  • Pharmaceutical studies and practices

Samjin Pharm (South Korea)
 2024

 Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies
OPENALEX - Publications 
Sungho Bea Dongwon Yoon Han Eol Jeong Juhong Jung Seung-Mok Park and 4 more Juhee Jeon Young‐Min Ye Jae‐Hyun Lee Ju‐Young Shin

Following the withdrawal of propacetamol in Europe owing to safety issues, regulatory authority South Korea requested a post-marketing surveillance study investigate its profile.

10.3349/ymj.2023.0207 article EN cc-by-nc Yonsei Medical Journal 2024-01-01
 A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization
OPENALEX - Publications 
Han Eol Jeong Sungho Bea Dongwon Yoon Juhong Jung Seung-Mok Park and 4 more Juhee Jeon Young‐Min Ye Jae‐Hyun Lee Ju‐Young Shin

Abstract Upon withdrawal of propacetamol, an injectable formulation the paracetamol prodrug, in Europe due to safety concerns, South Korea’s regulatory body requested a post-marketing surveillance study exploring its profile. We characterized regional disparities adverse events (AE) associated with propacetamol between Asia and using World Health Organization’s pharmacovigilance database, VigiBase. performed disproportionality analyses reporting odds ratios (rOR) information component (IC)...

10.1038/s41598-022-26211-0 article EN cc-by Scientific Reports 2022-12-13
Coming Soon ...